Oval Medical Technologies company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

ovalmedical.com

Stage

Acquired | Acquired

Total Raised

$2M

About Oval Medical Technologies

Oval Medical Technologies designs and develops drug delivery devices focusing on vials, prefilled syringes, and autoinjectors.

Oval Medical Technologies Headquarter Location

The Innovation Centre Unit 23 Cambridge Science Park Milton Road

Cambridge, England, CB4 0EY,

United Kingdom

+44 (0) 1223 437 140

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Oval Medical Technologies Patents

Oval Medical Technologies has filed 50 patents.

The 3 most popular patent topics include:

  • Dosage forms
  • Drug delivery devices
  • Medical equipment
patents chart

Application Date

Grant Date

Title

Related Topics

Status

1/25/2019

5/10/2022

Drug delivery devices, Dosage forms, Medical equipment, Drug culture, Drug paraphernalia

Grant

Application Date

1/25/2019

Grant Date

5/10/2022

Title

Related Topics

Drug delivery devices, Dosage forms, Medical equipment, Drug culture, Drug paraphernalia

Status

Grant

Latest Oval Medical Technologies News

Prefilled Syringes Market Size to Surpass US$ 15.56 Bn by 2030

Mar 23, 2022

Companies Covered Baxter International Inc., SCHOTT AG, West Pharmaceutical Services, Inc., Weigao Group, SHL Medical AG, Vetter Pharma International GmbH, Nipro Corporation, Terumo, Elcam Medical, Oval Medical Technologies Report Highlights On the basis of type, the segment named safety prefilled syringes is anticipated to foresee the highest growth rate during the forthcoming time period primarily due to the growing elderly population worldwide and presence of the rapies of biological for patients suffering from chronic diseases alleviates some of the pressure on hospitals. On the basis of material, the glass prefilled syringes segment accounted for the largest share of the prefilled syringes in 2020. On the basis of design, the single- chamber prefilled syringes segment accounted for the largest share of the prefilled syringes market. Europe is one of the major profit-generating regions in the market of prefilled syringes. Growing chronic diseases frequency, rise of the biosimilar and biologics market, geographical expansion by crucial manufacturers, growing population, technological advancements, and high adoption of self-injection equipment’s are boosting the demand for prefilled syringes which are self-injectable are the key factors boosting the growth of the prefilled syringes market in the European region. Ask here for more customization study@ https://www.precedenceresearch.com/customization/1575 Market Dynamics Driver: Rising target complaint population Prefilled syringes are substantially used for the treatment of chronic diseases, similar as diabetes, heart conditions, and autoimmune conditions, which bear patients to self-administer specifics. As a result, the adding prevalence and frequency of chronic and life conditions across the globe is a major factor contributing to the growth of the prefilled syringes market. Also, there's a growing demand for self-injection equipments, considering the convenience and safety associated with their use. Restraint: Dearth of prefilled syringes with intertwined safety features Prefilled syringes give better safety of patient by diminishing the potential for unintended needle sticks and poisonous products exposure that can do while drawing drug from vials. In similar patients, the defiled needle of prefilled syringes can lead to blood- borne infections, similar as HIV and HCV. In addition, the partial prefilled syringes market presence with intertwined safety features, due to their challenging and expensive manufacturing procedure, is a major concern in the market. Still, this trend is anticipated to change in the coming times, as the healthcare market is laying lesser emphasis on reducing the rate of needle stick injuries, which, in turn, is paving the way for the development of safety prefilled hypes. Opportunity: Growing healthcare structure across arising markets Emerging economies will continue to suffer from inadequate healthcare backing, which negatively affects access to quality, healthcare, and, eventually, the health status of citizens. According to the World Bank, roughly 400 million people lacks access to essential healthcare services, substantially in Africa and South Asia. Likewise, accelerating medical affectation, the cost of medical treatments and an advanced frequency of non-communicable life- related conditions similar as diabetes, cancer, or cardiac arrest, have rebounded in funding gaps. According Geneva Association report, in the last 20 years, the share of the aggregate global healthcare expenditure in GDP has raised from about 8% to nearly 10%, or an estimated US$8000 billion per year, which is boosted by the expanding treatment options, medical treatment accelerating cost and adding client demands. Also, the Global Burden of Disease Health Financing Collaborator Network (2017) estimates that global spending on health will nearly triple to USD 24 trillion by 2040 with upper-middle- income countries are estimated to show the fastest increase at a normal of5.3% per time. This growth could be attributed to uninterrupted growth in GDP and the rise of the middle class and government spending. Related Reports Challenge: Availability of cheaper alternatives Traditionally, injectable were painful and invasive in nature, which was the major concern for patients to prefer medicine delivery alternate routes, such as topical, oral, and nasal. In addition, among the various routes of medicine delivery, the oral route is the most preferred as it's easy to use, accessible, cost-effective, safe, and respectable. Due to the above mentioned factors, the adoption of indispensable medicine delivery technologies is adding across the globe. Like, cost-effective delivery styles development for insulin, alternate, similar as Medtronic's Veo insulin and Pfizer's Exubera pump, is restraining the usage of injectable insulin. Presently, insulin is substantially administered via injections, and therefore, injections of insulin form a significant market for injectable medicine delivery technologies. Still, the arrival of inhalable insulin is anticipated to significantly impact the growth of this market as nasal medicine delivery is pain-free and largely patient biddable. Market Segmentation Buy this Premium Research Report@  https://www.precedenceresearch.com/checkout/1575 You can place an order or ask any questions, please feel free to contact at  sales@precedenceresearch.com  | +1 9197 992 333 About Us Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally. For Latest Update Follow Us:

  • Where is Oval Medical Technologies's headquarters?

    Oval Medical Technologies's headquarters is located at The Innovation Centre Unit 23, Cambridge.

  • What is Oval Medical Technologies's latest funding round?

    Oval Medical Technologies's latest funding round is Acquired.

  • How much did Oval Medical Technologies raise?

    Oval Medical Technologies raised a total of $2M.

  • Who are the investors of Oval Medical Technologies?

    Investors of Oval Medical Technologies include SMC, SyndicateRoom and AptarGroup.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.